Long-term Treatment With Oral Sildenafil in Addition to Continuous IV Epoprostenol in Patients With Pulmonary Arterial Hypertension
- 1 April 2003
- Vol. 123 (4) , 1293-1295
- https://doi.org/10.1378/chest.123.4.1293
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Combination Therapy with Oral Sildenafil and Inhaled Iloprost for Severe Pulmonary HypertensionAnnals of Internal Medicine, 2002
- Sildenafil in HIV-related pulmonary hypertensionAIDS, 2001
- Aerosolised iloprost improves pulmonary haemodynamics in patients with primary pulmonary hypertension receiving continuous epoprostenol treatmentThorax, 2001
- Trials of inhaled Iloprost and other new vasodilating prostaglandinsEuropean Respiratory Journal, 2001
- Sildenafil in Primary Pulmonary HypertensionNew England Journal of Medicine, 2000
- Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertensionHeart, 2000
- Long-Term Prostacyclin for Pulmonary Hypertension With Associated Congenital Heart DefectsCirculation, 1999
- Reduction in Pulmonary Vascular Resistance with Long-Term Epoprostenol (Prostacyclin) Therapy in Primary Pulmonary HypertensionNew England Journal of Medicine, 1998
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Treatment of primary pulmonary hypertension intravenous epoprostenol (prostacyclin).Heart, 1987